Croatia Pharmaceuticals & Healthcare Q1 2019
Croatia’s pharmaceutical market is forecast to grow modestly in the coming years, driven by the medical needs of anageing population. However, opportunities for innovative drugmakers will remain limited by the precarious state of the healthcaresystem's financing. Although an increase in insurance contributions will increase HZZO revenues, the healthcare system requiresgreater reform. Furthermore, aggressive medicine price cuts implemented by the government in recent years and its pro-genericdrug stance will continue to negatively impact the outlook for patented drug sales in the country.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook